[Humoral immunity in chronic renal failure]. 1983

K Osaki, and H Otsuka, and K Uomizu, and T Morita, and S Miyazawa, and R Harada, and Y Otsuji, and S Hashimoto

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008934 Mitogens Substances that stimulate mitosis and lymphocyte transformation. They include not only substances associated with LECTINS, but also substances from streptococci (associated with streptolysin S) and from strains of alpha-toxin-producing staphylococci. (Stedman, 25th ed) Mitogen,Phytomitogen,Phytomitogens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody
D001402 B-Lymphocytes Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation. B-Cells, Lymphocyte,B-Lymphocyte,Bursa-Dependent Lymphocytes,B Cells, Lymphocyte,B Lymphocyte,B Lymphocytes,B-Cell, Lymphocyte,Bursa Dependent Lymphocytes,Bursa-Dependent Lymphocyte,Lymphocyte B-Cell,Lymphocyte B-Cells,Lymphocyte, Bursa-Dependent,Lymphocytes, Bursa-Dependent

Related Publications

K Osaki, and H Otsuka, and K Uomizu, and T Morita, and S Miyazawa, and R Harada, and Y Otsuji, and S Hashimoto
July 1979, Sovetskaia meditsina,
K Osaki, and H Otsuka, and K Uomizu, and T Morita, and S Miyazawa, and R Harada, and Y Otsuji, and S Hashimoto
January 2019, Cardiovascular & hematological disorders drug targets,
K Osaki, and H Otsuka, and K Uomizu, and T Morita, and S Miyazawa, and R Harada, and Y Otsuji, and S Hashimoto
July 1981, Vrachebnoe delo,
K Osaki, and H Otsuka, and K Uomizu, and T Morita, and S Miyazawa, and R Harada, and Y Otsuji, and S Hashimoto
April 1974, Orvosi hetilap,
K Osaki, and H Otsuka, and K Uomizu, and T Morita, and S Miyazawa, and R Harada, and Y Otsuji, and S Hashimoto
January 1973, Acta medica Academiae Scientiarum Hungaricae,
K Osaki, and H Otsuka, and K Uomizu, and T Morita, and S Miyazawa, and R Harada, and Y Otsuji, and S Hashimoto
January 1972, Marseille medical,
K Osaki, and H Otsuka, and K Uomizu, and T Morita, and S Miyazawa, and R Harada, and Y Otsuji, and S Hashimoto
January 1980, La Chirurgia degli organi di movimento,
K Osaki, and H Otsuka, and K Uomizu, and T Morita, and S Miyazawa, and R Harada, and Y Otsuji, and S Hashimoto
March 1979, Revista de medicina de la Universidad de Navarra,
K Osaki, and H Otsuka, and K Uomizu, and T Morita, and S Miyazawa, and R Harada, and Y Otsuji, and S Hashimoto
October 1975, Pathologie-biologie,
K Osaki, and H Otsuka, and K Uomizu, and T Morita, and S Miyazawa, and R Harada, and Y Otsuji, and S Hashimoto
July 2020, Immunology and cell biology,
Copied contents to your clipboard!